Compared with other treatments, combination therapy with ICAM‐1–Dxd and B7‐H3‐CD3 significantly elevated the concentrations of tumor‐suppressive cytokines, including TNF‐α, IL‐6, and IFN‐γ, to a greater extent (Figure S27, Supporting Information). Here, CD276 is linked to neoplasm.